Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy

The increased use of targeted therapy and immune checkpoint inhibitors in cancers has brought new hope of survival to patients with advanced tumors. However, increasing numbers of immune‐related adverse events (irAEs) of these medications have been reported, affecting almost all human organs includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaowei, Wang, Zheng, Zhao, Chan, Wang, Hanping, Guo, Xiaoxiao, Zhou, Jiaxin, Duan, Lian, Si, Xiaoyan, Zhang, Li, Li, Yue, Wang, Mengzhao, Zhang, Meifen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Clinical Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049480/
https://www.ncbi.nlm.nih.gov/pubmed/32017399
http://dx.doi.org/10.1111/1759-7714.13327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049480/
https://www.ncbi.nlm.nih.gov/pubmed/32017399
http://dx.doi.org/10.1111/1759-7714.13327

Ejemplares similares